The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Esina L.V.
National Medical Research Center for Hematology;
Sechenov First Moscow State Medical University
Therapy of mental disorders in patients with hematological malignancies
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(4): 127‑136
Views: 633
Downloaded: 6
To cite this article:
Vybornykh DE, Ivanov SV, Gemdzhian EG, Esina LV, Gaponova TV. Therapy of mental disorders in patients with hematological malignancies. S.S. Korsakov Journal of Neurology and Psychiatry.
2024;124(4):127‑136. (In Russ.)
https://doi.org/10.17116/jnevro2024124041127
To assess the possibilities of therapy with minimal effective doses (MED) of psychotropic drugs for mental disorders (MD) that manifest during the treatment of hematological malignancies (HM).
A prospective study was conducted at the National Medical Research Center for Hematology of the Russian Ministry of Health (Moscow), which included 204 (39.4%) men and 314 (60.6%) women (518 patients in total), aged 17 to 83 years (median 45 years), with various HM, in which the manifestation of MD occurred during the treatment of the underlying disease. To minimize the side-effects of psychotropic drugs and given the relatively mild level of MD, psychopharmacotherapy of patients was carried out mainly at MED. The severity of MD, manifested in patients, was assessed by the illness severity scale of the Clinical Global Impression (CGI) scale, and the effectiveness of the treatment was assessed by the improvement scale (CGI-I).
Mainly mild (188, 36%) and moderately pronounced (270, 52%) MD were noted in patients with HM during the treatment of the underlying disease. Severe psychopathological disorders (60, 12%) were observed much less often. Because of psychopharmacotherapy with MED, patients experienced a very significant (97, 19%) and significant improvement (354, 68%) of their mental state, less often the improvement was regarded as minimal (67, 13%). Therefore, almost all patients showed a stable relief of MD; in 87% (95% CI 84—90) of patients, this improvement was significant.
The tactics of treatment MD that manifest in patients with HM with MED of psychotropic drugs turned out to be therapeutically effective according to the results of the assessment on CGI scales.
Keywords:
Authors:
Esina L.V.
National Medical Research Center for Hematology;
Sechenov First Moscow State Medical University
Received:
07.07.2023
Accepted:
21.01.2024
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.